Updates

EpicentRx and Texas Children’s Cancer Center announce the initiation of a Phase 1 clinical trial with RRx-001 for pediatric CNS tumors

02/24/2022 Health Briefs

min. read

Topics

Read

Full media story at www.epicentrx.com

For Physicians Dec 19, 2025

How Texas Children’s Is Revolutionizing LCH Care with Precision Medicine and Research

Health Briefs Nov 10, 2025

Duncan NRI participates in 2025 Walk to End Alzheimer's

Health Briefs Nov 03, 2025

Texas Children’s Fellow Honored with ASH Abstract Achievement Award

Health Briefs Nov 01, 2025

Research Administration Participates in Halloween Celebrations

Health Briefs Oct 11, 2025

Epilepsy Youth Forum at the Duncan NRI

Health Briefs Oct 07, 2025

FDA grants Breakthrough Therapy Designation to Angelman Syndrome treatment

See more results